Japanese researchers identify the role of interleukin-36 receptor antagonist in cutaneous ischemia-reperfusion injury (IMAGE)

Fujita Health University

Japanese researchers identify the role of interleukin-36 receptor antagonist in cutaneous ischemia-reperfusion injury

Caption

Researchers from Fujita Health University School of Medicine, and Nagoya University Graduate School of Medicine, Japan, studied the role of interleukin-36 (IL-36) receptor antagonist in wound healing caused by ischemia-reperfusion injury, using IL-36 knockout (KO) mice, compared to wildtype (WT) mice, and have identified associated immunological mechanisms, along with potential therapeutic targets.

Credit

Yoshihito Tanaka from Fujita Health University

Usage Restrictions

You are free to share and adapt the material. Attribution is required.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.